Global /India /Healthcare /Drug Manufacturers - General /SAKAR

Sakar Healthcare Ltd.

SAKAR

• NSE: SAKAR • Delayed

628.05INR 0.4%

6.65 USD

As of 20 June 2026, Sakar Healthcare Ltd. has a market cap of $147.49M USD, ranking #22974 globally and #1352 in India. It ranks #2065 in the Healthcare sector, and #746 in the Drug Manufacturers - General industry.

Global Rank

22974

Country Rank

1352

Sector Rank

2065

Industry Rank

746

Key Stats

Market Cap

$147.49MUSD

13.92B INR

Enterprise Value

$156.42MUSD

14.77B INR

Revenue (TTM)

$24.52MUSD

2.31B INR

EBITDA (TTM)

$6.11MUSD

576.69M INR

Net Income (TTM)

$2.67MUSD

252.21M INR

EBITDA Margin

25%

Profit Margin

11%

PE Ratio

55.0

PS Ratio

6.0

PB Ratio

4.6

EV/EBITDA

25.6

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

342

Founded

2004

Website

sakarhealthcare.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.4%	1.7%	21%	65%	77%	53%	117%	189%	438%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	SAKAR Sakar Healthcare Ltd ISIN: INE732S01012 Shares Out.: Shares Outstanding: 21.95M¹ Shares Float: 4.462M² TV: TradingView: NSE: SAKAR SA: Stock Analysis: NSE: SAKAR YF: Yahoo Finance: SAKAR.NS GF: Google Finance: NSE: SAKAR BA: Barron's: SAKAR MS: Morningstar: XNSE: SAKAR	628.05 INR	TV: TradingView: NSE: SAKAR SA: Stock Analysis: NSE: SAKAR YF: Yahoo Finance: SAKAR.NS GF: Google Finance: NSE: SAKAR BA: Barron's: SAKAR MS: Morningstar: XNSE: SAKAR

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Sakar Healthcare Ltd.

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaesthetic, bronchodilator, adrenergic, sedative, anti-inflammatory, antiemetic, anticonvulsant, antipsychotic, antidepressant, and anti-cancer. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 31K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 12K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 10K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 8K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 7K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 6K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 516K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 371K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 244K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 216K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 193K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 186K%	15.1	United States

chevron_leftBack